Evaluations & learnings

Evaluations provide independent assessments of our work, help us make adjustments and plan for the future.

Our evaluation framework is based on the internationally accepted evaluation framework of the Organization for Economic Co-operation and Development’s Development Assistance Committee, including its principles and criteria for grant evaluations. The framework was updated in 2022 to align with our 2023-2027 Strategy.

We require at least one evaluation for each investment or portfolio of investments, typically conducted within 12 months of closure. We also conduct prospective evaluations to facilitate real-time learning and thematic evaluations to review performance and capture learning within cross-cutting areas of our strategic framework.

Upcoming evaluations

There are no current evaluations planned. Check back regularly for updates.

June 2022

Unitaid HIV Self Testing (HIVST) area for intervention – Joint end of project evaluation

Evaluation report

April 2022

Mid-term evaluation of Unitaid’s COVID-19 portfolio of investments

Evaluation report

Mid-term evaluation of Unitaid’s COVID-19 portfolio of investments – Supporting Appendices

Evaluation report

September 2021

End-of-grant evaluation Medicines Patent Pool (MPPII)

Evaluation report

August 2021

Transforming IPT for Optimal Pregnancy (TIPTOP) Project and Output 1 of the Supply Side Grant, End-of-Grant Evaluation Report

Evaluation report

July 2021

Unitaid investments in Hepatitis C – portfolio evaluation and end-of-project evaluations of the FIND HEAD-Start and Coalition PLUS grants

Evaluation report

July 2021

Joint End-of-Grant Evaluations – Point-of-Care Molecular Diagnostics for HIV

Evaluation report

July 2021

End-of-Project Evaluation of the HIV Self-Testing AfRica (STAR) Initiative

Evaluation report
1 2 3 4 8